Ergomed (ERGO)

 

ERGO Share PerformanceMore

52 week high172.00 08/01/16
52 week low117.00 16/09/16
52 week change -51.50 (-30.03%)
4 week volume333,359 04/09/16

Latest NewsMore

Ergomed revenues up

Half-year Report

RNS Number: 7528K Ergomed plc 26 September 2016 PRESS RELEASE Unaudited Interim results for the six months ended 30 June 2016 Strong first half financial performance - revenues up 21% and gross profit up 26% 19 million new contracts signed resulting in a backlog of 60 million Acquisitions of O+P and GASD strengthens service business Acquisition of Ha...

Ergomed contract win

Ergomed says that following its recent acquisitions of Dr Oestreich + Partner and Gesellschaft fr angewandte Statistik + D...

Contract win validates rationale of acquisitions

RNS Number: 4981K Ergomed plc 22 September 2016 Ergomed's full service contract win validates strategic rationale of recent acquisitions London, UK - 22 September 2016: Ergomed plc, (LSE: ERGO or 'Ergomed' or "the Group") announces that, following its recent acquisitions of Dr. Oestreich + Partner GmbH ('O+P') and Gesellschaft fr angewandte Statistik + Date...

Ergomed receives a "buy" recommendation

RNS Number: 0683K Ergomed plc 16 September 2016 GBC Research initiates coverage of Ergomed plc with a "buy" recommendation and target price of GBP 2.73 (EUR 3.22) per share Potential upside of more than 128% compared to AIM closing price of GBP 1.20 the day prior to publication of the report GBC's recommendation based on Ergomed's profitability, with...

Ergomed completes clinical trial recruitment

Ergomed has completed recruitment in a phase IIa clinical trial of lorediplon in patients with insomnia disorder. Under Er...

Recruitment completed in phase IIa clinical trial

RNS Number: 2253J Ergomed plc 08 September 2016 PRESS RELEASE FOR IMMEDIATE RELEASE Ergomed completes recruitment of Phase IIa clinical trial of lorediplon in insomnia in collaboration with co-development partner Ferrer Results expected at the end of the year London, UK - 8 September 2016: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company...

Notice of Results

RNS Number: 2000J Ergomed plc 07 September 2016 PRESS RELEASE FOR IMMEDIATE RELEASE Notice of Interim Results London, UK - 7 September 2016: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, w...

Fundamental DataMore

P/E ratio22.222
EPS5.4
Dividend yield0 %

Latest discussion posts More

  • Webinar with management

    We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...
    26-Sep-2016
    equity_dev

Users' HoldingsMore

Users who hold Ergomed also hold..
GOLDEN PROS33%
LENOVO33%
BANGO33%
GVC HLDGS33%
LAKEHOUSE33%

Codes & Symbols

ISINGB00BN7ZCY67
SymbolsERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO